Announced Thu, 23 Jul · 15:51 IST
Compliance Certificate Filed Under SEBI Reg 74(5) for June 2026 Quarter
Compliance View source PDF
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+8.0%1-day move
₹153.17
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+8.0+7.1————————
Up moveDown movePending
AI summary
Nath Bio-Genes (India) Ltd submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate, issued by RTA Bigshare Services Pvt. Ltd. on 14 July 2026, confirms that securities received for dematerialization were processed, listed on stock exchanges, and original certificates were cancelled within 15 days. CFO Amol Gupta signed the filing.
Likely market impact
Routine regulatory compliance filing. No material impact on shareholders or stock price.